S. J. Choi

发表

The PDGF-C regulatory region SNP rs28999109 decreases promoter transcriptional activity and is associated with CL/P

P. Sulima, M. Marazita, J. Murray, 2009, European Journal of Human Genetics.

Macrophage inflammatory protein-1alpha is an osteoclastogenic factor in myeloma that is independent of receptor activator of nuclear factor kappaB ligand.

G. Roodman, N. Kurihara, Y. Oba, 2001, Blood.

Characterization of Immortalized Osteoclast Precursors Developed from Mice Transgenic for Both bcl-XL and Simian Virus 40 Large T Antigen.

S. Reddy, G. Roodman, T. Hentunen, 1999, Endocrinology.

ADAM8 Enhances Osteoclast Precursor Fusion and Osteoclast Formation In Vitro and In Vivo

M. Subler, D. Galson, G. Roodman, 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

α9β1: A Novel Osteoclast Integrin That Regulates Osteoclast Formation and Function

D. Sheppard, G. Roodman, N. Kurihara, 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Eosinophil Chemotactic Factor‐L (ECF‐L): A Novel Osteoclast Stimulating Factor

G. Roodman, H. Chung, Y. Oba, 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Macrophage inflammatory protein 1-alpha is a potential osteoclast stimulatory factor in multiple myeloma.

F. Craig, G. Roodman, R. Devlin, 2000, Blood.

Antisense inhibition of macrophage inflammatory protein 1-α blocks bone destruction in a model of myeloma bone disease

G. Roodman, Y. Gazitt, M. Alsina, 2001 .

Proteolysis of Macrophage Inflammatory Protein-1α Isoforms LD78β and LD78α by Neutrophil-derived Serine Proteases*

Rong-Fong Shen, Wells W. Wu, E. Fıratlı, 2005, Journal of Biological Chemistry.

IL-3 expression by myeloma cells increases both osteoclast formation and growth of myeloma cells.

N. Callander, G. Roodman, D. Jelinek, 2004, Blood.

ADAM8: A Novel Osteoclast Stimulating Factor

G. Roodman, S. J. Choi, Je-Ho Han, 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

expression in multiple myeloma α AML-1A and AML-1B regulation of MIP-1

N. Callander, G. David, D. Jelinek, 2013 .

Gingival Epithelial Cell Expression of Macrophage Inflammatory Protein-1α Induced by Interleukin-1β and Lipopolysaccharide.

T. Hart, I. S. Song, O. Ryu, 2007, Journal of periodontology.

AML-1A and AML-1B regulation of MIP-1α expression in multiple myeloma

N. Callander, G. Roodman, D. Jelinek, 2003 .

MIP-1α utilizes both CCR1 and CCR5 to induce osteoclast formation and increase adhesion of myeloma cells to marrow stromal cells

N. Callander, G. Roodman, D. Jelinek, 2005 .

A 4 bp deletion mutation in DLX3 enhances osteoblastic differentiation and bone formation in vitro.

Rong-Fong Shen, Wells W. Wu, T. Hart, 2008, Bone.

Mutant tamm-horsfall glycoprotein accumulation in endoplasmic reticulum induces apoptosis reversed by colchicine and sodium 4-phenylbutyrate.

T. Hart, A. Bleyer, I. S. Song, 2005, Journal of the American Society of Nephrology : JASN.

Identification of Human Asparaginyl Endopeptidase (Legumain) as an Inhibitor of Osteoclast Formation and Bone Resorption*

S. Reddy, R. Devlin, B. Boyce, 1999, The Journal of Biological Chemistry.

myeloma IL-3 is a potential inhibitor of osteoblast differentiation in multiple

S. Colla, G. David, I. Ghobrial, 2013 .

IL-3 is a potential inhibitor of osteoblast differentiation in multiple myeloma.

S. Colla, G. Roodman, I. Ghobrial, 2005, Blood.

MIP-1 alpha and myeloma bone disease.

G. Roodman, G. Roodman, S. J. Choi, 2004, Cancer treatment and research.

AML-1A and AML-1B regulation of MIP-1alpha expression in multiple myeloma.

N. Callander, G. Roodman, D. Jelinek, 2003, Blood.

Eosinophil Chemotactic Factor‐L (ECF‐L) Enhances Osteoclast Formation by Increasing ICAM‐1 Expression

G. Roodman, N. Kurihara, H. Chung, 2006, Annals of the New York Academy of Sciences.

Normalizing the bone marrow microenvironment with p38 inhibitor reduces multiple myeloma cell proliferation and adhesion and suppresses osteoclast formation.

G. Roodman, N. Kurihara, G. Schreiner, 2006, Experimental cell research.

Osteoclast Inhibitory Peptide 2 Inhibits Osteoclast Formation via Its C‐Terminal Fragment

G. Roodman, N. Kurihara, S. J. Choi, 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Macrophage inﬂammatory protein-1 a is an osteoclastogenic factor in myeloma that is independent of receptor activator of nuclear factor k B ligand

G. Roodman, N. Kurihara, Y. Oba, 2001 .

Macrophage inflammatory protein-1 a is an osteoclastogenic factor in myeloma that is independent of receptor activator of nuclear factor kB ligand

G. Roodman, N. Kurihara, Y. Oba, 2001 .

MIP-1alpha utilizes both CCR1 and CCR5 to induce osteoclast formation and increase adhesion of myeloma cells to marrow stromal cells.

N. Callander, G. Roodman, D. Jelinek, 2005, Experimental hematology.

MMP20 Active-site Mutation in Hypomaturation Amelogenesis Imperfecta

M. Ozdemir-Karatas, T. Hart, N. Piesco, 2005, Journal of dental research.

Macrophage inflammatory protein-1alpha is an osteoclastogenic factor in myeloma that is independent of receptor activator of nuclear factor kappaB ligand.

G. Roodman, N. Kurihara, S. J. Choi, 2001, Blood.

Characterization of immortalized osteoclast precursors developed from mice transgenic for both bcl-X(L) and simian virus 40 large T antigen.

S. Reddy, G. Roodman, T. Hentunen, 1999 .